Evidence map›Paper›PMID 42399235›Full record

ArticleBlood cancer journal2026

Response profile and long-term outcomes in Cyclin D1-overexpressing multiple myeloma: insights from the CASSIOPEIA trial.

Aurore Perrot, Cyrille Touzeau, Stéphane Minvielle, Cyrille Hulin, Denis Caillot, Salomon Manier, Xavier Leleu, Cécile Sonntag, Karim Belhadj, Bertrand Arnulf and 11 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Aurore PerrotUniversité de Toulouse, Centre Hospitalier Universitaire de Toulouse, IUCT Oncopole, Service Hématologie, Toulouse, France. perrot.aurore@iuct-oncopole.fr.ORCID http://orcid.org/0000-0003-0131-8689
Cyrille TouzeauHematology Department, University Hospital Hôtel-Dieu, Nantes, France.ORCID http://orcid.org/0000-0003-0275-2575
Stéphane MinvielleCRCI2NA, INSERM UMR 1307, CNRS UMR 6075, Nantes University Hospital, Nantes, France.ORCID http://orcid.org/0000-0003-1389-312X
Cyrille HulinDepartment of Hematology, Hôpital Haut Lévêque, University Hospital, Pessac, France.ORCID http://orcid.org/0000-0002-3749-5161
Denis CaillotDepartment of Hematology, Institut de Cancérologie de Bourgogne, Dijon, France.ORCID http://orcid.org/0009-0009-6985-5609
Salomon ManierDepartment of Hematology, Lille University Hospital and INSERM UMR-S1277 and CNRS UMR9020, Lille, France.ORCID http://orcid.org/0000-0001-7653-711X
Xavier LeleuUniversity of Poitiers, Centre Hospitalier Universitaire and INSERM 1313, Poitiers, France.ORCID http://orcid.org/0000-0002-9822-4170
Cécile SonntagUniversity Hospital, Hôpital Hautepierre, Strasbourg, France.
Karim BelhadjUnité Fonctionnelle Hémopathies Lymphoïdes, Centre Hospitalier Universitaire Henri Mondor, Créteil, France.
Bertrand ArnulfImmuno-hématologie, Hôpital Saint Louis, APHP, Université Paris Cité, Paris, France.
Thomas ChalopinService d'Hématologie et Thérapie Cellulaire, CHU Tours, Hôpital Bretonneau, Tours, France.ORCID http://orcid.org/0000-0002-9833-3115
Jean-Richard EveillardBrest University Hospital, Hôpital A Morvan, Brest, France.
Martine Escoffre-BarbeHematology Department, CHU Rennes, Rennes, France.
Lionel KarlinLyon University Hospital, Hematology Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
Laure VincentCHU Montpellier - Hôpital St Eloi, Service d'hématologie clinique, Montpellier, France.ORCID http://orcid.org/0000-0001-5904-1286
Margaret MacroCentre Hospitalier Universitaire de Caen, Caen, France.
Hervé Avet-LoiseauUnité de Génomique du Myélome, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse - Oncopole, Université de Toulouse, Toulouse, France.
Soraya WuillemeHematology Biology, Nantes University Hospital, Nantes, France.
Ariane BoumendilIntergroupe Francophone du Myélome, Paris, France.
Jill CorreUnité de Génomique du Myélome, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse - Oncopole, Université de Toulouse, Toulouse, France.ORCID http://orcid.org/0000-0003-1580-6106
Philippe MoreauHematology Department, University Hospital Hôtel-Dieu, Nantes, France.ORCID http://orcid.org/0000-0003-1780-8746

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42399235
PMCPMC13332210

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.